IG wants benchmark pricing for drugs

Share this content:

The Department of Health and Human Services Office of Inspector General would like to see a national drug pricing benchmark. In a letter to the Centers for Medicare & Medicaid Services, the IG said the move save on Medicaid reimbursement costs paid to pharmacies. The letter said most states use a “fundamentally flawed” method to calculate such payments. The report said CMS is in agreement and is taking steps to provide guidance to states on this issue.


Next Article in Products